This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 25/12/2502    most recent 01.ATV.0000190663.88143.97v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nakata, S. Articles by Yanagihara, N. Search for Related Content PubMed PubMed Citation Articles by Nakata, S. Articles by Yanagihara, N. Related Collections Endothelium/vascular type/nitric oxide

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:2502.)
© 2005 American Heart Association, Inc.

Vascular Biology

Vascular Neuronal NO Synthase Is Selectively Upregulated by Platelet-Derived Growth Factor

Involvement of the MEK/ERK Pathway

Sei Nakata; Masato Tsutsui; Hiroaki Shimokawa; Masahito Tamura; Hiromi Tasaki; Tsuyoshi Morishita; Osamu Suda; Susumu Ueno; Yumiko Toyohira; Yasuhide Nakashima; Nobuyuki Yanagihara

From the Second Department of Internal Medicine (S.N., M.T., H.T., T.M., O.S., Y.N.) and the Department of Pharmacology (M.T., S.U., Y.T., N.Y.), School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan; and the Department of Cardiovascular Medicine (H.S.), Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.

Correspondence to Masato Tsutsui, MD, PhD, Department of Pharmacology, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan. E-mail mt2498{at}med.uoeh-u.ac.jp

Objective— We demonstrated recently that neuronal NO synthase (NOS) is expressed in arteriosclerotic lesions and exerts important vasculoprotective effects in vivo. In this study, we examined the molecular mechanism(s) for vascular neuronal NOS (nNOS) expression.

Methods and Results— In cultured rat aortic smooth muscle cells, treatment with platelet-derived growth factor (PDGF) selectively upregulated nNOS expression but not inducible NOS (iNOS) or endothelial NOS (eNOS) expression. Treatment with PDGF also significantly caused activation of mitogen-activated protein kinase (MAPK) family, including extracellular signal-regulated kinase (ERK), p38MAPK, and c-Jun N-terminal kinase (JNK). ERK kinase (MAPK kinase [MEK]) inhibitors inhibited PDGF-induced nNOS expression, whereas a p38MAPK inhibitor or JNK inhibitor was without effects. Importantly, gene transfer of MEK per se elicited nNOS induction, and gene transfer of dominant-negative MEK abolished PDGF-induced nNOS expression. In isolated aortas of wild-type, eNOS^–/–, and iNOS^–/– mice, but not in those of nNOS^–/– mice, treatment with PDGF significantly enhanced nNOS expression and nitrite plus nitrate production, both of which were again attenuated by a MEK inhibitor.

Conclusions— These results provide the first evidence that vascular nNOS expression is upregulated selectively in response to PDGF through the MEK/ERK pathway. Upregulated nNOS may play an important compensatory role under arteriosclerotic/inflammatory conditions associated with eNOS dysfunction to maintain vascular homeostasis.

This study demonstrates that vascular neuronal NO synthase (nNOS) expression is selectively upregulated in response to platelet-derived growth factor via activation of the ERK cascade. Upregulated nNOS may play an important compensatory role in the presence of reduced endothelial NOS activity (eg, arteriosclerosis) to maintain vascular homeostasis.

Key Words: ERK • mitogen-activated protein kinase • neuronal nitric oxide synthase • nitric oxide • platelet-derived growth factor

This article has been cited by other articles:

				G.-X. Zhang, S. Kimura, K. Murao, J. Shimizu, H. Matsuyoshi, and M. Takaki Role of neuronal NO synthase in regulating vascular superoxide levels and mitogen-activated protein kinase phosphorylation Cardiovasc Res, February 1, 2009; 81(2): 389 - 399. [Abstract] [Full Text] [PDF]

				E. Carrier, I. Brochu, A. J. de Brum-Fernandes, and P. D'Orleans-Juste The Inducible Nitric-Oxide Synthase Modulates Endothelin-1-Dependent Release of Prostacyclin and Inhibition of Platelet Aggregation ex Vivo in the Mouse J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 972 - 978. [Abstract] [Full Text] [PDF]

				S. Nakata, M. Tsutsui, H. Shimokawa, T. Yamashita, A. Tanimoto, H. Tasaki, K. Ozumi, K. Sabanai, T. Morishita, O. Suda, et al. Statin Treatment Upregulates Vascular Neuronal Nitric Oxide Synthase Through Akt/NF-{kappa}B Pathway Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 92 - 98. [Abstract] [Full Text] [PDF]

				C. V. Garat, D. Fankell, P. F. Erickson, J. E.-B. Reusch, N. N. Bauer, I. F. McMurtry, and D. J. Klemm Platelet-Derived Growth Factor BB Induces Nuclear Export and Proteasomal Degradation of CREB via Phosphatidylinositol 3-Kinase/Akt Signaling in Pulmonary Artery Smooth Muscle Cells. Mol. Cell. Biol., July 1, 2006; 26(13): 4934 - 4948. [Abstract] [Full Text] [PDF]